Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lisanne Noordam, Monique T.A. de Beijer, Shanta Mancham, Isabel Vogler, Patrick P.C. Boor, Valeska de Ruiter, Robbie Luijten, Jan N.M. IJzermans, Ugur Sahin, Marco J. Bruno, Dave Sprengers, Sonja I. Buschow & Jaap Kwekkeboom. (2022) Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients. OncoImmunology 11:1.
Read now
Read now
Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura, Norihiro Fujinami & Tetsuya Nakatsura. (2021) Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances. Journal of Hepatocellular Carcinoma 8, pages 1035-1054.
Read now
Read now
Lijie Xia, Qiao Teng, Qi Chen & Fuchun Zhang. (2020) Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma. International Journal of Nanomedicine 15, pages 2197-2205.
Read now
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Read now
Nobuhiro Tsuchiya, Ako Hosono, Toshiaki Yoshikawa, Kayoko Shoda, Kazuto Nosaka, Manami Shimomura, Junichi Hara, Chika Nitani, Atsushi Manabe, Hiroki Yoshihara, Yosuke Hosoya, Hide Kaneda, Yoshiaki Kinoshita, Kenichi Kohashi, Kenichi Yoshimura, Norihiro Fujinami, Keigo Saito, Shoichi Mizuno & Tetsuya Nakatsura. (2018) Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors. OncoImmunology 7:1.
Read now
Read now
Articles from other publishers (42)
Jing Ning, Jianqiao Ding, Shu Wang, Youhong Jiang, Daqing Wang & Shenyi Jiang. (2023) GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells. Journal of Immunology Research 2023, pages 1-22.
Crossref
Crossref
My Thi Viet Ha, Hiroshi Hamana, Kiyomi Shitaoka, Abdul Hayee, Eiji Kobayashi, Toshiaki Yoshikawa, Tetsuya Nakatsura, Reiko Saikawa, Eri Sato, Mitsujiro Osawa, Yasumichi Hitoshi, Tung Son Dang, Tatsuhiko Ozawa & Hiroyuki Kishi. (2023) Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers. Cancer Science 114:6, pages 2254-2264.
Crossref
Crossref
Tingting Li, Ciying Qian, Ying Gu, Jun Zhang, Shaowei Li & Ningshao Xia. (2022) Current progress in the development of prophylactic and therapeutic vaccines. Science China Life Sciences 66:4, pages 679-710.
Crossref
Crossref
Cheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, Guang-Xiao Meng, Chun-Cheng Yang, Hui Liu, Zi-Niu Ding, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen & Tao Li. (2022) Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades. Journal of Cancer Research and Clinical Oncology 149:4, pages 1425-1441.
Crossref
Crossref
Patrick M. McCarthy, Franklin A. Valdera, Todd R. Smolinsky, Alexandra M. Adams, Anne E. O’Shea, Katryna K. Thomas, Spencer Van Decar, Elizabeth L. Carpenter, Ankur Tiwari, John W. Myers, Diane F. Hale, Timothy J. Vreeland, George E. Peoples, Alex Stojadinovic & Guy T. Clifton. (2023) Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials. Frontiers in Immunology 14.
Crossref
Crossref
Xiaoqing Shi, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, Junnian Zheng & Dafei Chai. (2023) HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma. iScience 26:3, pages 106143.
Crossref
Crossref
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi & Massoud Vosough. (2023) Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future. European Journal of Cell Biology 102:1, pages 151284.
Crossref
Crossref
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis & Athanasios G. Papavassiliou. (2022) Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 23:21, pages 13612.
Crossref
Crossref
Yanyan Zheng, Zheng Lu, Jiage Ding, Nan Jiang, Jiawei Wang, Jie Yang, Jingyuan Song, Hongliang Chen, Lin Fang, Huizhong Li, Hui Tian, Gang Wang, Junnian Zheng & Dafei Chai. (2022) Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma. Cancers 14:18, pages 4512.
Crossref
Crossref
Chun-Ye Zhang, Shuai Liu & Ming Yang. (2022) Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy. World Journal of Gastroenterology 28:27, pages 3346-3358.
Crossref
Crossref
Markus W. Löffler, Stefania Gori, Francesco Izzo, Andrea Mayer-Mokler, Paolo A. Ascierto, Alfred Königsrainer, Yuk Ting Ma, Bruno Sangro, Sven Francque, Luisa Vonghia, Alessandro Inno, Antonio Avallone, Jörg Ludwig, Diego Duarte Alcoba, Christian Flohr, Katrin Aslan, Regina Mendrzyk, Heiko Schuster, Marco Borrelli, Danila Valmori, Tanguy Chaumette, Regina Heidenreich, Cécile Gouttefangeas, Greta Forlani, Maria Tagliamonte, Caterina Fusco, Roberta Penta, Mercedes Iñarrairaegui, Ulrike Gnad-Vogt, Carsten Reinhardt, Toni Weinschenk, Roberto S. Accolla, Harpreet Singh-Jasuja, Hans-Georg Rammensee & Luigi Buonaguro. (2022) Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma. Clinical Cancer Research 28:12, pages 2555-2566.
Crossref
Crossref
Chao Wang, Min Shi, Lei Zhang, Jun Ji, Ruyan Xie, Chao Wu, Xianchao Guo, Ying Yang, Wei Zhou, Chenhong Peng, Henghui Zhang, Fei Yuan & Jun Zhang. (2021) Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma. Cancer Immunology, Immunotherapy 71:2, pages 491-504.
Crossref
Crossref
Anita Bakrania, Gang Zheng & Mamatha Bhat. (2021) Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment. Pharmaceutics 14:1, pages 41.
Crossref
Crossref
Orsolya Lőrincz, József Tóth, Levente Molnár, István Miklós, Kata Pántya, Mónika Megyesi, Eszter Somogyi, Zsolt Csiszovszki & Enikő R. Tőke. (2021) In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines. Cells 10:11, pages 3048.
Crossref
Crossref
Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera & Chinnasamy Thirunavukkarasu. (2021) Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy. Cell Biology International 45:11, pages 2161-2177.
Crossref
Crossref
Gbemisola Lawal, Yao Xiao, Amir A. Rahnemai-Azar, Diamantis I. Tsilimigras, Ming Kuang, Anargyros Bakopoulos & Timothy M. Pawlik. (2021) The Immunology of Hepatocellular Carcinoma. Vaccines 9:10, pages 1184.
Crossref
Crossref
Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen & Arunya Jiraviriyakul. (2021) The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomedical Reports 15:4.
Crossref
Crossref
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh & Mathias Heikenwalder. (2021) Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 7:7, pages 606-623.
Crossref
Crossref
Hongbo Ni, Jian Xue, Fan Wang, Xiaohan Sun & Meng Niu. (2021) Nanomedicine Approach to Immunotherapy of Hepatocellular Carcinoma. Journal of Biomedical Nanotechnology 17:5, pages 771-792.
Crossref
Crossref
Tanja Gerlza, Christina Trojacher, Nikola Kitic, Tiziana Adage & Andreas J. Kungl. (2021) Development of Molecules Antagonizing Heparan Sulfate Proteoglycans. Seminars in Thrombosis and Hemostasis 47:03, pages 316-332.
Crossref
Crossref
Kazuto Takahashi, Kazuya Ofuji, Katsushi Hiramatsu, Takuto Nosaka, Tatsushi Naito, Hidetaka Matsuda, Katsuya Endo, Masayuki Higuchi, Masahiro Ohtani, Tomoyuki Nemoto & Yasunari Nakamoto. (2021) Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma. Cancer Medicine 10:7, pages 2300-2309.
Crossref
Crossref
Ligong Lu, Jun Jiang, Meixiao Zhan, Hui Zhang, Qian‐Ting Wang, Sheng‐Nan Sun, Xiao‐Kai Guo, Hua Yin, Yadong Wei, Shi‐You Li, Jun O. Liu, Yong Li & You‐Wen He. (2021) Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies. Hepatology 73:2, pages 821-832.
Crossref
Crossref
Feng Wang, Ning Zhao, Ge Gao, Hong-Bin Deng, Zhi-Hui Wang, Li-Li Deng, Yu Yang & Changlian Lu. (2020) Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology 146:11, pages 2851-2859.
Crossref
Crossref
H. Daiko, T. Marafioti, T. Fujiwara, Y. Shirakawa, T. Nakatsura, K. Kato, I. Puccio, T. Hikichi, S. Yoshimura, T. Nakagawa, M. Furukawa, K. Stoeber, M. Nagira, N. Ide & T. Kojima. (2020) Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients. Cancer Immunology, Immunotherapy 69:11, pages 2247-2257.
Crossref
Crossref
Fatemeh Motamedi Dehbarez, Navid Nezafat & Shirin Mahmoodi. (2020)
In Silico
Design of a Novel Multi-Epitope Peptide Vaccine Against Hepatocellular Carcinoma
. Letters in Drug Design & Discovery 17:9, pages 1164-1176.
Crossref
Crossref
Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed & Anwaar Saeed. (2020) Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma. Vaccines 8:3, pages 447.
Crossref
Crossref
Masatake Taniguchi, Shoichi Mizuno, Toshiaki Yoshikawa, Norihiro Fujinami, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda & Tetsuya Nakatsura. (2020) Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis. Cancer Science 111:8, pages 2747-2759.
Crossref
Crossref
Yu Akazawa, Yuki Saito, Toshiaki Yoshikawa, Keigo Saito, Kazuto Nosaka, Manami Shimomura, Shoichi Mizuno, Yasunari Nakamoto & Tetsuya Nakatsura. (2020) Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer. Cancer Science 111:8, pages 2736-2746.
Crossref
Crossref
Nancy A. Espinoza-Sánchez & Martin Götte. (2020) Role of cell surface proteoglycans in cancer immunotherapy. Seminars in Cancer Biology 62, pages 48-67.
Crossref
Crossref
Shuxia Liu, Minjie Wang, Cuiling Zheng, Qiaofeng Zhong, Yuankai Shi & Xiaohong Han. (2020) Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer. Clinical Biochemistry 79, pages 54-60.
Crossref
Crossref
Yu Akazawa, Ako Hosono, Toshiaki Yoshikawa, Hide Kaneda, Chika Nitani, Junichi Hara, Yoshiaki Kinoshita, Kenichi Kohashi, Atsushi Manabe, Miki Fukutani, Masashi Wakabayashi, Akihiro Sato, Kayoko Shoda, Manami Shimomura, Shoichi Mizuno, Yasunari Nakamoto & Tetsuya Nakatsura. (2019) Efficacy of the NCCV Cocktail‐1 vaccine for refractory pediatric solid tumors: A phase I clinical trial. Cancer Science 110:12, pages 3650-3662.
Crossref
Crossref
Mariana Aris, Alicia Inés Bravo, Heli Magalí Garcia Alvarez, Ibel Carri, Enrique Podaza, Paula Alejandra Blanco, Cecilia Rotondaro, Sofia Bentivegna, Morten Nielsen, María Marcela Barrio & José Mordoh. (2019) Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood. Frontiers in Immunology 10.
Crossref
Crossref
Yu Akazawa, Daisuke Nobuoka, Mari Takahashi, Toshiaki Yoshikawa, Manami Shimomura, Shoichi Mizuno, Toshiyoshi Fujiwara, Yasunari Nakamoto & Tetsuya Nakatsura. (2019) Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes. Cancer Science 110:6, pages 1842-1852.
Crossref
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Itaru Endo & Tetsuya Nakatsura. (2019) Next-Generation Cancer Immunotherapy Targeting Glypican-3. Frontiers in Oncology 9.
Crossref
Crossref
Marina Okada, Yoshitaka Tada, Tomohisa Seki, Shugo Tohyama, Jun Fujita, Toshihiro Suzuki, Manami Shimomura, Kazuya Ofuji, Yoshikazu Kishino, Kazuaki Nakajima, Sho Tanosaki, Shota Someya, Hideaki Kanazawa, Satoru Senju, Tetsuya Nakatsura & Keiichi Fukuda. (2019) Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3. Biochemical and Biophysical Research Communications 511:3, pages 711-717.
Crossref
Crossref
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto & Tetsuya Nakatsura. (2019) Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma. World Journal of Meta-Analysis 7:3, pages 80-95.
Crossref
Crossref
Yuan-yong Liu, Wei Sha, Shiqiang Xu, Xu-wei Gui, Liliang Xia, Ping Ji, Shujun Wang, Guo-ping Zhao, Xiao Zhang, Yingying Chen & Ying Wang. (2018) Identification of HLA-A2-Restricted Mycobacterial Lipoprotein Z Peptides Recognized by T CellsFrom Patients With ActiveTuberculosis Infection. Frontiers in Microbiology 9.
Crossref
Crossref
Jian Li, Tiezheng Wang, Boxun Jin, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song & Ning Li. (2018) Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis. The International Journal of Biological Markers 33:4, pages 353-363.
Crossref
Crossref
Nikos K. Karamanos, Zoi Piperigkou, Achilleas D. Theocharis, Hideto Watanabe, Marco Franchi, Stéphanie Baud, Stéphane Brézillon, Martin Götte, Alberto Passi, Davide Vigetti, Sylvie Ricard-Blum, Ralph D. Sanderson, Thomas Neill & Renato V. Iozzo. (2018) Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics. Chemical Reviews 118:18, pages 9152-9232.
Crossref
Crossref
Xitian Liang, Bolin Wu, Haitao Shang, Xue Han, Hui Jing, Yixin Sun & Wen Cheng. (2018) VTIQ evaluates antitumor effects of NET‑1 siRNA by UTMD in HCC xenograft models. Oncology Letters.
Crossref
Crossref
Naofumi Mukaida & Yasunari Nakamoto. (2018) Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma. World Journal of Gastroenterology 24:17, pages 1839-1858.
Crossref
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo & Tetsuya Nakatsura. (2018) Cancer immunotherapy-targeted glypican-3 or neoantigens. Cancer Science 109:3, pages 531-541.
Crossref
Crossref